Concepts (64)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Adenoviridae | 6 | 2008 | 128 | 0.320 |
Why?
|
| Viral Vaccines | 4 | 2009 | 54 | 0.250 |
Why?
|
| Genetic Vectors | 7 | 2009 | 889 | 0.230 |
Why?
|
| Vaccines, Synthetic | 4 | 2009 | 78 | 0.160 |
Why?
|
| Smallpox Vaccine | 2 | 2009 | 16 | 0.140 |
Why?
|
| Vaccinia virus | 2 | 2009 | 73 | 0.140 |
Why?
|
| SAIDS Vaccines | 2 | 2008 | 22 | 0.130 |
Why?
|
| Capsid Proteins | 3 | 2006 | 103 | 0.130 |
Why?
|
| Adenoviridae Infections | 2 | 2007 | 5 | 0.130 |
Why?
|
| CD8-Positive T-Lymphocytes | 3 | 2008 | 679 | 0.110 |
Why?
|
| Cross Reactions | 3 | 2009 | 134 | 0.090 |
Why?
|
| Gene Products, gag | 3 | 2008 | 67 | 0.090 |
Why?
|
| Immunity, Cellular | 3 | 2009 | 178 | 0.090 |
Why?
|
| Neutralization Tests | 5 | 2009 | 127 | 0.080 |
Why?
|
| Macaca mulatta | 5 | 2009 | 256 | 0.080 |
Why?
|
| Simian Immunodeficiency Virus | 2 | 2006 | 81 | 0.070 |
Why?
|
| Smallpox | 1 | 2008 | 10 | 0.070 |
Why?
|
| Immunodominant Epitopes | 1 | 2006 | 57 | 0.060 |
Why?
|
| Adenoviruses, Human | 1 | 2005 | 10 | 0.060 |
Why?
|
| Reassortant Viruses | 1 | 2005 | 10 | 0.060 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2006 | 184 | 0.060 |
Why?
|
| Genetic Engineering | 1 | 2006 | 117 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 6 | 2007 | 3450 | 0.050 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2008 | 645 | 0.050 |
Why?
|
| Immunization, Secondary | 3 | 2009 | 50 | 0.050 |
Why?
|
| Mice | 7 | 2008 | 11003 | 0.040 |
Why?
|
| Animals | 9 | 2009 | 20961 | 0.040 |
Why?
|
| Antigens, Viral | 2 | 2009 | 137 | 0.030 |
Why?
|
| Immunoenzyme Techniques | 2 | 2006 | 109 | 0.030 |
Why?
|
| Serotyping | 2 | 2007 | 53 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2008 | 458 | 0.030 |
Why?
|
| Immunization | 2 | 2008 | 135 | 0.030 |
Why?
|
| Antibodies, Viral | 2 | 2009 | 329 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 2 | 2008 | 891 | 0.030 |
Why?
|
| Defective Viruses | 1 | 2009 | 4 | 0.020 |
Why?
|
| Fowlpox virus | 1 | 2009 | 4 | 0.020 |
Why?
|
| Genetic Therapy | 2 | 2006 | 802 | 0.020 |
Why?
|
| Ectromelia virus | 1 | 2008 | 1 | 0.020 |
Why?
|
| AIDS Vaccines | 1 | 2009 | 72 | 0.020 |
Why?
|
| Chemoprevention | 1 | 2008 | 41 | 0.020 |
Why?
|
| Interleukin-2 | 1 | 2008 | 167 | 0.020 |
Why?
|
| Viral Envelope Proteins | 1 | 2008 | 102 | 0.020 |
Why?
|
| Africa South of the Sahara | 1 | 2007 | 21 | 0.020 |
Why?
|
| Seroepidemiologic Studies | 1 | 2007 | 53 | 0.020 |
Why?
|
| Body Weight | 1 | 2008 | 379 | 0.020 |
Why?
|
| DNA Primers | 1 | 2007 | 295 | 0.020 |
Why?
|
| Cloning, Molecular | 1 | 2007 | 386 | 0.020 |
Why?
|
| DNA, Recombinant | 1 | 2006 | 47 | 0.020 |
Why?
|
| Viral Proteins | 1 | 2008 | 266 | 0.020 |
Why?
|
| Antibodies | 1 | 2006 | 186 | 0.010 |
Why?
|
| Interferon-gamma | 1 | 2008 | 576 | 0.010 |
Why?
|
| Injections, Intramuscular | 1 | 2005 | 72 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2007 | 416 | 0.010 |
Why?
|
| Antibody Formation | 1 | 2005 | 114 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2008 | 616 | 0.010 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2005 | 99 | 0.010 |
Why?
|
| Membrane Glycoproteins | 1 | 2008 | 671 | 0.010 |
Why?
|
| Vaccines | 1 | 2006 | 98 | 0.010 |
Why?
|
| Epitopes | 1 | 2005 | 292 | 0.010 |
Why?
|
| Base Sequence | 1 | 2007 | 1332 | 0.010 |
Why?
|
| Virus Replication | 1 | 2005 | 323 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2007 | 1997 | 0.010 |
Why?
|
| Humans | 2 | 2009 | 64238 | 0.010 |
Why?
|
| Female | 1 | 2006 | 33350 | 0.000 |
Why?
|